Biological Products, Except Diagnostic Substances (Biotech) - Insider Trading Data

Insiders are officers, directors, or significant investors. This page shows insider sentiment and transactions for the Biological industry. Research shows that insider trades are predictive of future stock returns. By examining insider trades for an industry, we can understand what well-informed people think of the overall future industry prospects.

Biological Products, Except Diagnostic Substances (Biotech) - Insider Buy/Sell Ratio

Insider selling and buying is a useful indicator for analyzing the market because it serves as a proxy for their optimism or pessimism in their own companies. By looking at ratio of total selling and buying across the entire market, we might be able to draw some conclusions about the future market.

We offer two charts here. The first one shows the total dollar volume of buying and selling by insiders. The second chart shows the ratio of the number of insiders selling, vs. the number of insiders buying. In both charts, we filter out trades made by indirect holders (such as trusts), and 10% owners (who, although considered an 'insider' by the SEC, do not actually manage the companies in which they are considered insiders).

Corporate Insider Buy Sell Ratio (Dollar Volume) - Biological Products, Except Diagnostic Substances (Biotech)
Corporate Insider Buy Sell Ratio (Insider Count) - Biological Products, Except Diagnostic Substances (Biotech)
Biological Products, Except Diagnostic Substances (Biotech) - Transaction History

Click the link icon to see the full transaction history. Transactions reported as part of a 10b5-1 automatic trading plan will have an X in the column marked 10b-5.

Tran
Date
Security Form Insider Code 10b5-1 Direct Share
Price
Shares
Changed
2025-09-03 APGE / Apogee Therapeutics, Inc. 4 Dambkowski Carl S - Sale D 37.82 -2,535
2025-09-03 VOR / Vor Biopharma Inc. 4 Reprogrammed Interchange LLC S - Sale D 1.9961 -554,612
2025-09-03 APGE / Apogee Therapeutics, Inc. 4 Dambkowski Carl S - Sale D 38.55 -190
2025-09-03 EDIT / Editas Medicine, Inc. 4 Burkly Linda S - Sale D 2.5961 -710
2025-09-03 EDIT / Editas Medicine, Inc. 4 O'Neill Gilmore Neil S - Sale D 2.5961 -5,592
2025-09-03 RVMD / Revolution Medicines, Inc. 4 Anders Jack S - Sale D 40.1742 -5,238
2025-09-03 RVMD / Revolution Medicines, Inc. 4 Anders Jack M - Exercise D 17 2,049
2025-09-03 CGON / CG Oncology, Inc. 4 POST LEONARD E M - Exercise D 0.6 1,000
2025-09-03 RVMD / Revolution Medicines, Inc. 4 Anders Jack M - Exercise D 4.73 3,189
2025-09-03 HALO / Halozyme Therapeutics, Inc. 4 Torley Helen M - Exercise D 8.11 20,000
2025-09-03 DNLI / Denali Therapeutics Inc. 4 Watts Ryan J. G - Gift I -50,000
2025-09-03 NBIX / Neurocrine Biosciences, Inc. 4 Onyia Jude G - Gift D -1,470
2025-09-03 RGEN / Repligen Corporation 4 Loeillot Olivier F - Taxes D 116.18 -2,506
2025-09-03 PLX / Protalix BioTherapeutics, Inc. 4 Boudes Pol F By Trust A - Award I 7,500
2025-09-03 KYMR / Kymera Therapeutics, Inc. 4 Adams Brian A - Award D 52,500
2025-09-03 PLX / Protalix BioTherapeutics, Inc. 4 Bar-Shalev Amos By Trust A - Award I 7,500
2025-09-03 PLX / Protalix BioTherapeutics, Inc. 4 Ben Zvi Shmuel By Trust A - Award I 7,500
2025-09-03 PLX / Protalix BioTherapeutics, Inc. 4 Bashan Dror By Trust A - Award I 195,000
2025-09-03 PLX / Protalix BioTherapeutics, Inc. 4 Elze Christian By Trust A - Award I 7,500
2025-09-03 PLX / Protalix BioTherapeutics, Inc. 4 Naos Yaron By Trust A - Award I 25,000
2025-09-03 PLX / Protalix BioTherapeutics, Inc. 4 Melincoff Gwen A By Trust A - Award I 7,500
2025-09-03 PLX / Protalix BioTherapeutics, Inc. 4 Forster Eliot By Trust A - Award I 7,500
2025-09-03 PLX / Protalix BioTherapeutics, Inc. 4 Schwartz Aharon By Trust A - Award I 7,500
2025-09-02 ALEC / Alector, Inc. 4 Kenkare-Mitra Sara S - Sale D 2.4968 -23,638
2025-09-02 ALEC / Alector, Inc. 4 Rosenthal Arnon S - Sale D 2.4968 -51,562
2025-09-02 RVMD / Revolution Medicines, Inc. 4 Anders Jack S - Sale D 40.0168 -4,762
2025-09-02 ADAP / Adaptimmune Therapeutics plc - Depositary Receipt (Common Stock) 4 Wood Gavin S - Sale D 0.0099 -96,000
2025-09-02 HALO / Halozyme Therapeutics, Inc. 4 Connaughton Bernadette S - Sale D 74.111 -923
2025-09-02 ALEC / Alector, Inc. 4 Wong-Sarad Grace S - Sale D 2.4968 -5,910
2025-09-02 ALEC / Alector, Inc. 4 Berkley Neil Lindsay S - Sale D 2.4968 -15,842
2025-09-02 VCEL / Vericel Corporation 4 Hopper Jonathan Mark S - Sale D 35.77 -10,000
2025-09-02 HALO / Halozyme Therapeutics, Inc. 4 Torley Helen S - Sale D 73.698 -16,288
2025-09-02 HALO / Halozyme Therapeutics, Inc. 4 Torley Helen S - Sale D 74.147 -3,412
2025-09-02 VIR / Vir Biotechnology, Inc. 4 SATO VICKI L S - Sale D 4.9914 -22,000
2025-09-02 HALO / Halozyme Therapeutics, Inc. 4 Connaughton Bernadette S - Sale D 71.71 -100
2025-09-02 BIIB / Biogen Inc. 4 Singhal Priya S - Sale D 133.55 -517
2025-09-02 HALO / Halozyme Therapeutics, Inc. 4 Connaughton Bernadette S - Sale D 73.618 -2,977
2025-09-02 HALO / Halozyme Therapeutics, Inc. 4 Torley Helen S - Sale D 72.485 -300
2025-09-02 RVMD / Revolution Medicines, Inc. 4 Anders Jack M - Exercise D 2.68 2,814
2025-09-02 IOVA / Iovance Biotherapeutics, Inc. 4 Vogt Frederick G M - Exercise D 52,086
2025-09-02 IOVA / Iovance Biotherapeutics, Inc. 4 Puri Raj K. M - Exercise D 5,470
2025-09-02 HALO / Halozyme Therapeutics, Inc. 4 Torley Helen M - Exercise D 8.11 20,000
2025-09-02 IOVA / Iovance Biotherapeutics, Inc. 4 GRAF FINCKENSTEIN FRIEDRICH M - Exercise D 12,697
2025-09-02 RVMD / Revolution Medicines, Inc. 4 Anders Jack M - Exercise D 4.73 1,948
2025-09-02 VCEL / Vericel Corporation 4 Hopper Jonathan Mark M - Exercise D 18 10,000
2025-09-02 IOVA / Iovance Biotherapeutics, Inc. 4 BILINSKY IGOR M - Exercise D 12,306
2025-09-02 NBIX / Neurocrine Biosciences, Inc. 4 SHERWIN STEPHEN A G - Gift D -1,000
2025-09-02 IOVA / Iovance Biotherapeutics, Inc. 4 Puri Raj K. F - Taxes D 2.19 -2,467
2025-09-02 PCVX / Vaxcyte, Inc. 4 PICKERING GRANT F - Taxes D 31.56 -2,857
2025-09-02 IOVA / Iovance Biotherapeutics, Inc. 4 GRAF FINCKENSTEIN FRIEDRICH F - Taxes D 2.19 -6,448
P
Köp på öppna marknaden eller privat köp av icke-derivatsäkerhet
S
Köp på öppna marknaden eller privat försäljning av icke-derivatsäkerhet
A
Bevilja, tilldelning eller annat förvärv av värdepapper från företaget (såsom en option)
C
Omvandling av derivat
D
Försäljning eller överföring av värdepapper tillbaka til företaget
F
Betalning av lösenpris eller skatteskuld med del av värdepapper som erhållits från bolaget
G
Överlåtelse av värdepapper från eller till insidern
K
Aktieswappar och liknande säkringsaffärer
M
Utövande eller omvandling av derivatsäkerhet som erhållits från företaget (som en option)
V
En transaktion friviligt rapporterad på schema 4
J
Andra (med en fotnot som beskriver transaktionen)